Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:28 AM ET 10-Q
Financial Results Novavax Inc NVAX

Novavax Q3 2026 Results: Net Loss of $31.4M, Loss Narrows

Novavax reported total revenue of $68.3 million for the third quarter of 2026, a slight decrease from $70.4 million in the prior year, while net loss narrowed significantly to $31.4 million compared to $202.4 million. For the nine-month period, the company experienced a net loss of $94.3 million, a sharp reversal from the $422.8 million net income recorded in the same period of 2025, primarily due to a substantial drop in product sales and licensing revenue.

Key figure
Net loss $31.4M
8:27 AM ET 10-Q
Financial Results Holley Inc. HLLY

Holley Q3 2026 Results: Turns Profitable, Net Income $7.82M

For the thirty-nine weeks ended September 27, 2026, Holley Inc. reported net sales of $460.9 million and net income of $12.7 million, remaining relatively flat compared to the prior year. The company experienced a significant $28.6 million loss on the sale of assets during the period, which was offset by lower interest expenses and favorable fair value adjustments on liabilities.

Key figure
Net income $7.82M
8:27 AM ET 8-K
Financial Results Vivmark Residential VMRK

Vivmark Residential Financial Results

Vivmark Residential reported its first quarterly results following the August 2026 merger of equals between Equity Residential and AvalonBay Communities. The company increased its expected annual net run-rate operating synergies to $135 million and lowered its total expected merger-related costs to $725 million.

Term
Q3 2026

“In our first quarter as Vivmark, we delivered operating results ahead of plan and are increasing our expectations for synergies and upfront value creation. In addition to these strong financial results, we are advancing our priorities of using our scale and capabilities to deliver more responsive service, better digital tools and greater convenience for our residents.”

Benjamin W. Schall, President and CEO
8:23 AM ET 8-K
Financial Results Holley Inc. HLLY

Holley Financial Results

Holley Inc. reported third quarter 2026 net sales of $141.6 million, representing 2.3% growth year-over-year, and achieved its year-end leverage target of 3.5x a quarter early. The company reduced its debt by $25 million during the quarter and reported net income of $7.8 million compared to a net loss in the prior year period.

Term
Q3 2026

“Our third quarter results reflect the continued strength of our core business, which has now grown in six of the last seven quarters, and the progress we are making against our strategic priorities. Our teams delivered that performance in a moderating macroeconomic environment, which makes their execution even more impressive, and I am proud of what they accomplished.”

Matthew Stevenson, President and Chief Executive Officer

“The third quarter demonstrated continued progress across sales growth, profitability, cash generation, and balance sheet strength. We delivered year-over-year Adjusted EBITDA growth of 8.6% and generated $8.8 million of free cash flow, a $3.3 million improvement year-over-year, reflecting our continued focus on operational execution and financial discipline.”

Jesse Weaver, Chief Financial Officer
8:21 AM ET 8-K
Financial Results National Fuel Gas Co NFG

National Fuel Gas Financial Results

National Fuel Gas Company reported fiscal year 2026 GAAP earnings of $7.02 per share and adjusted earnings of $7.55 per share, a 9% increase year-over-year. The company also announced a strategic plan to separate its Integrated Upstream and Gathering business into a standalone publicly traded company named Seneca Resources by the second half of 2027.

Term
FY2026

“Fiscal 2026 was an excellent year for National Fuel. The Company grew adjusted earnings per share 9% year over year, while generating significant free cash flow and continuing to return cash to our shareholders through our dividend, which we’ve paid for the 124th consecutive year.”

David P. Bauer, President and Chief Executive Officer

“As we look forward, National Fuel is entering an exciting next chapter. The long-term outlook for each of our businesses is strong. With the closing of our Ohio gas utility acquisition and our announced plan to separate our Integrated Upstream and Gathering business, we are well positioned to establish two scaled, financially sound publicly traded natural gas businesses.”

David P. Bauer, President and Chief Executive Officer
8:20 AM ET Form 4
Insider Buying Donegal Group Inc DGICB

Donegal Group Insider Donegal Mutual Insurance Co Buys $282K of Stock

Donegal Mutual Insurance Co bought 15,000 shares of Donegal Group Inc at $18.69 to $18.93 a share (average $18.81) in 2 transactions, worth $282K in total between Nov 3, 2026 and Nov 4, 2026. Shares held after the trade: 14,402,128 (+0.1%).

Value
$282K
Shares
15,000
Average price
$18.81
Holding change
+0.1%
Trade date
Nov 3, 2026 to Nov 4, 2026
8:18 AM ET 10-Q
Financial Results White Mountains Insurance Group Ltd WTM

White Mountains Insurance Group Q3 2026 Results: Net Loss of $39M

White Mountains reported total revenues of $2.0 billion for the first nine months of 2026, down from $2.1 billion in the prior year, primarily due to investment losses in the third quarter. The company completed the sale of the Bamboo Group during the period and saw significant growth in its Specialty Insurance Distribution and WTM Partners segments through acquisitions.

Key figure
Net loss $39M
8:17 AM ET 8-K
Financial Results Priority Technology Holdings, Inc. PRTH

Priority Technology Holdings Financial Results

Priority Technology Holdings reported Q3 2026 revenue of $268.6 million, an 11.3% increase year-over-year, though net income fell 55.7% to $12.2 million. The company noted its pending go-private merger with WD Capital Partners for $8.05 per share is expected to close in the first half of 2027. Due to the pending acquisition, the company has suspended providing forward-looking guidance and will no longer host earnings conference calls.

Term
Q3 2026
8:17 AM ET 8-K
Financial Results Imax Corp IMAX

Imax Financial Results

IMAX Corporation reported record-breaking third quarter 2026 financial results, achieving its best quarterly performance in company history driven by the success of Christopher Nolan’s 'The Odyssey'. The company saw revenue surge 64% to $175 million and global box office reach a record $712 million, while net income per diluted share rose 430% to $1.96.

Term
Q3 2026

“What IMAX achieved goes beyond simply a ‘great quarter’ and transcends the many records we shattered in the period. What we believe we are witnessing is an awakening to the power and potential of our platform to impact global culture, unlock new commercial opportunities, and inspire a new level of demand and awe in audiences around the world.”

Rich Gelfond, CEO of IMAX Corporation

“Christopher Nolan’s The Odyssey is a historic cinematic achievement crafted entirely with IMAX technology and its record-breaking success marks a new era of opportunity for our company. The record margins we generated in the quarter demonstrate the unique strength of our model, and the growing value of scarce events and experiences in an increasingly A.I.-driven world underscore a powerful opportunity for our business, as we look ahead to a remarkably strong slate over the next several years.”

Rich Gelfond, CEO of IMAX Corporation
8:17 AM ET 8-K
Financial Results Loar Holdings Inc. LOAR

Loar Holdings Financial Results

Loar Holdings reported record Q3 2026 net sales of $176.2 million, a 39% increase year-over-year, driven by 15.8% organic growth and recent acquisitions. While Adjusted EBITDA rose 46.5% to $71.9 million, net income declined to $19.6 million due to higher interest and tax expenses. The company also raised its financial outlook for both full-year 2026 and 2027.

“Our record results in the third quarter of 2026 reflects our continued successful execution along all our value drivers. Most noteworthy our operating cash flow for the quarter after being reduced by our capital expenditures were a record for the quarter improving 46% over the comparative previous year period.”

Dirkson Charles, Loar Holdings Chief Executive Officer and Executive Co-Chairman of the Board of Directors
8:16 AM ET 10-Q
Financial Results Cra International, Inc. CRAI

Cra International Q3 2026 Results: Net Income $13.9M, Up 21.2% YoY

CRA International reported fiscal year-to-date 2026 revenues of $626.7 million, a 13% increase over the prior year, though net income decreased slightly to $38.5 million. The company significantly increased its debt position with a new $72.9 million term loan and higher revolving credit usage to fund operations and $49.3 million in share repurchases.

Key figure
Net income $13.9M · +21.2% YoY
8:16 AM ET 8-K
Reverse Stock Split OFA Group OFAL

OFA Group Reverse Stock Split

OFA Group is effecting a 10-for-1 reverse stock split (share consolidation) of its Class A ordinary shares, effective November 10, 2026. The action is intended to increase the per-share trading price to support the company's continued listing on the Nasdaq Capital Market. The split will reduce the number of outstanding Class A shares from approximately 9 million to approximately 0.9 million.

8:16 AM ET 8-K
Financial Results Intellia Therapeutics, Inc. NTLA

Intellia Therapeutics Financial Results

Intellia Therapeutics reported Q3 2026 financial results, highlighting the FDA's acceptance and Priority Review of the BLA for lonvo-z with a PDUFA date of March 10, 2027. The company completed enrollment in its MAGNITUDE-2 Phase 3 trial for ATTRv-PN and expects its current cash position to fund operations into 2028.

Counterparty
Regeneron Pharmaceuticals, Inc.
Term
Q3 2026

“This is a defining period for Intellia as we advance our late-stage pipeline and prepare for a transformative year ahead. We have assembled the teams and capabilities needed to support a successful launch in HAE while also continuing to advance nex-z’s Phase 3 clinical trials and our pipeline expansion efforts. Looking to 2027, we are working toward a historic milestone: the potential approval of lonvo-z as the world’s first in vivo CRISPR-based therapy.”

John Leonard, M.D., Intellia President and Chief Executive Officer
8:16 AM ET 8-K
Financial Results Centuri Holdings, Inc. CTRI

Centuri Holdings Financial Results

Centuri Holdings reported record third-quarter 2026 revenue of $1.2 billion, a 40% year-over-year increase, driven by workforce investments and improved operational efficiency. The company achieved net income of $26.9 million and expanded its opportunity pipeline to a record $19 billion. Management issued preliminary 2027 targets including mid-teens revenue growth and gross profit margins between 8.5% and 9.0%.

Term
Q3 2026

“I am very pleased with our third quarter results that clearly demonstrate that investments made to build greater scale and capacity during the first half of the year, including our workforce additions, delivered the benefits we expected as productivity and efficiency improved across our operations.”

Christian Brown, President & CEO

“Commercial momentum remains strong across our end markets, supported by robust customer demand and significant opportunities across our core and adjacent end markets. Through the first three quarters of the year, we have secured approximately $2.9 billion of bookings.”

Christian Brown, President & CEO
8:14 AM ET 8-K
Financial Results White Mountains Insurance Group Ltd WTM

White Mountains Insurance Group Financial Results

White Mountains Insurance Group reported a 1% decrease in book value per share to $2,243 for Q3 2026, primarily driven by unrealized investment losses at MediaAlpha and the impact of higher interest rates on fixed income. Despite the investment headwinds, operating results were solid with Ark producing a 75% combined ratio and HG Global generating record gross written premiums of $19 million.

Term
Q3 2026

“Book value per share was down 1% in the quarter. Higher interest rates and a lower share price at MediaAlpha drove unrealized investment losses, which offset an otherwise solid quarter for operating results. Ark produced a 75% combined ratio and $386 million of gross written premiums, leading to strong growth in tangible book value.”

Liam Caffrey, CEO
8:12 AM ET 10-Q
Financial Results Acorn Energy, Inc. ACFN

Acorn Energy Q3 2026 Results: Net Income $940K, Up 273.0% YoY

Acorn Energy reported net income of $1.17 million for the nine months ended September 30, 2026, compared to $1.46 million in the prior year period. The company completed the acquisition of the Gen-Tracker business during the period, resulting in the recognition of $1.44 million in goodwill and $2.08 million in intangible assets.

Key figure
Net income $940K · +273.0% YoY
8:12 AM ET 8-K
Financial Results Hertz Global Holdings, Inc HTZ

Hertz Global Holdings Financial Results

Hertz reported its strongest quarterly revenue and Adjusted Corporate EBITDA in three years for Q3 2026, driven by strong pricing in its core U.S. rental business. Revenue rose 6% year-over-year to $2.6 billion, while Adjusted Corporate EBITDA reached $233 million, reflecting continued progress in the company's operational transformation.

Term
Q3 2026

“We delivered our strongest quarterly revenue and Adjusted Corporate EBITDA performance in three years, driven by continued revenue growth and margin expansion on flat capacity. The underlying progress in our core U.S. rental business is meaningful, and we see significant opportunity ahead as we continue to improve execution, expand our franchise model and build new sources of earnings and value across the Hertz platform.”

Gil West, Chief Executive Officer of Hertz
8:11 AM ET 8-K
Financial Results Cra International, Inc. CRAI

Cra International Financial Results

CRA International reported record third-quarter 2026 revenue of $214.9 million, a 15.6% increase year-over-year, driven by broad-based growth across its Legal & Regulatory and Management Consulting practices. The company increased its full-year 2026 revenue guidance and raised its quarterly dividend by 17.5% to $0.67 per share.

Term
Q3 2026

“CRA continues to build on its strong start to fiscal 2026 as third-quarter revenue increased 15.6% year over year to $214.9 million. This record top-line performance translated into the highest third-quarter profits in the company’s history as measured by net income, earnings per diluted share and EBITDA.”

Paul Maleh, CRA’s President and Chief Executive Officer

“Broad-based contributions once again characterized CRA’s financial performance, reflecting both the quality and the depth of our portfolio. Seven practices grew year over year, representing approximately 95% of the company’s total revenue for the third quarter.”

Paul Maleh, CRA’s President and Chief Executive Officer
8:11 AM ET 8-K
Financial Results Filana Therapeutics, Inc. FLNA

Filana Therapeutics Financial Results

Filana Therapeutics reported Q3 2026 financial results, including a net loss of $10.7 million and a cash balance of $47.0 million. The company announced that patient screening for its Phase 2a study of simufilam in TSC-related epilepsy is expected to begin by Q1 2027 following the recent lifting of an FDA clinical hold.

“Simufilam has the potential to make a meaningful difference for patients with TSC-related epilepsy. We began working toward activating clinical study sites as soon as FDA lifted the clinical hold in September. Patient screening is expected to begin by the first quarter of 2027.”

Rick Barry, President and Chief Executive Officer
8:10 AM ET 8-K
Business Update Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals Business Update

Processa Pharmaceuticals issued a stockholder letter outlining its strategic shift toward immunological and inflammatory (I&I) diseases following its July acquisition of Vidya Therapeutics. The company highlighted the advancement of its lead BTK inhibitor candidate, VT-7208, into Phase 2 development for food allergy, chronic spontaneous urticaria, and relapsing multiple sclerosis, supported by approximately $183.3 million in net cash proceeds.

8:10 AM ET 8-K
Financial Results Axcelis Technologies Inc ACLS

Axcelis Technologies Financial Results

Axcelis Technologies reported Q3 2026 revenue of $237.8 million and GAAP diluted EPS of $1.21, exceeding internal expectations. The company noted a strong increase in bookings and record revenue in its CS&I business, signaling a broadening recovery across Memory, Power, and General Mature end markets.

Term
Q3 2026

“We are pleased with our third quarter performance, as improving demand drove sequential growth in systems revenue, complemented by another quarterly record in CS&I. We are particularly encouraged by the strong increase in bookings, reflecting a broadening recovery across our end markets, with continued momentum in Memory and increasing activity in Power and General Mature.”

Russell Low, President and CEO

“Our third quarter results exceeded our expectations, supported by stronger shipments and record CS&I revenue, despite the impact from foreign exchange headwinds on our gross margin. We continue to generate healthy cash flow and maintain a strong balance sheet, providing us with ample financial flexibility.”

David Ryzhik, Senior Vice President and Interim CFO
8:10 AM ET 8-K
Financial Results Southern Power Co SO

Southern Power Financial Results

Southern Company reported third-quarter 2026 earnings of $2.0 billion, or $1.77 per share, compared to $1.7 billion in the prior year period. Operating revenues increased 13% to $8.8 billion, driven by warmer weather, customer growth, and increased usage from large commercial and industrial customers.

Term
Q3 2026

“The Southeast is growing at a pace that is both unprecedented and transformational, and we believe Southern Company is well positioned for today and in the future. Our scale, our experience and our customer-focused strategy allow us to serve this growing demand in a responsible and sustainable manner, with the same discipline, credibility and customer focus that have long defined our company.”

Chris Womack, chairman, president and CEO of Southern Company
8:10 AM ET 10-Q
Financial Results Core Scientific, Inc. CORZ ▶ Call

Core Scientific Q3 2026 Results: Turns Profitable, Net Income $1.18B

Core Scientific reported a significant shift in its business model, with colocation revenue growing to $215.4 million for the quarter ended September 30, 2026, compared to $15.0 million in the prior year, driven by high-performance computing (HPC) initiatives. Despite a net loss of $324.4 million for the nine-month period, the company achieved a net income of $1.18 billion in the third quarter, primarily due to a $1.03 billion favorable change in the fair value of warrant liabilities.

Key figure
Net income $1.18B
8:09 AM ET 8-K
Financial Results USA Today Co., Inc. TDAY

USA Today Co Financial Results

USA TODAY Co. reported third quarter 2026 total revenues of $519.2 million, a 7.4% year-over-year decrease, and a net loss of $4.6 million. The company announced a new $100 million annualized cost reduction program and plans to opportunistically repurchase shares using $96.9 million remaining in its authorized buyback program. Management also highlighted a $901 million damages calculation in its ongoing Ad Tech litigation against Google, with a trial date set for April 2027.

Term
Q3 2026

“In the third quarter, we felt the impacts of the changes in consumer search along with some inflationary pressures. At the same time, we saw encouraging underlying signals in the categories that we believe are most important to our future. Audience trends showed signs of stabilization, engagement strengthened across our platforms, and we continued to grow the digital revenue categories that are central to our strategy, including direct-sold digital advertising, digital-only subscriptions, and digital other.”

Michael Reed, Chairman and Chief Executive Officer

“At the end of the third quarter, we implemented our new $100 million annualized cost reduction program, establishing a lower cost structure that is already benefiting our fourth-quarter run rate. Together with the positive momentum across our digital portfolio, we expect these improvements to drive significant sequential growth in Adjusted EBITDA and free cash flow, as well as substantial margin expansion in the fourth quarter.”

Michael Reed, Chairman and Chief Executive Officer
8:09 AM ET 8-K
Financial Results Novavax Inc NVAX

Novavax Financial Results

Novavax reported Q3 2026 total revenue of $68 million and raised its full-year 2026 revenue guidance to $400 million at the mid-point. The company also earned a $125 million milestone payment from partner Sanofi following the initiation of a Phase 3 combination vaccine trial in Europe.

“This quarter, we continued to execute across all three pillars of our strategy. Our partner Sanofi initiated their Phase 3 influenza-COVID-19 combination vaccine trial vaccine trial in Europe, triggering a $125 million milestone payment. Our focused R&D efforts are building a growing body of data on what our technology can do in infectious disease, advancing our C. difficile candidate towards the clinic and exploring oncology as a potential new area of application. And we have been doing this while continuing to reduce expenses and operate with financial discipline. Over time, we believe this strategy can build a robust and profitable Novavax, with multiple partners and products, diversified revenue streams and a meaningful impact on global health.”

John C. Jacobs, President and Chief Executive Officer, Novavax
8:09 AM ET 8-K
Investor Presentation Camden National Corp CAC

Camden National Investor Presentation

Camden National Corporation has prepared a formal investor presentation for use in upcoming meetings with investors and analysts. The presentation, filed as Exhibit 99.1, provides a strategic and operational overview of the company's performance and market position in the Northern New England region.

8:08 AM ET 8-K
Financial Results Insight Enterprises Inc NSIT

Insight Enterprises Financial Results

Insight Enterprises reported Q3 2026 financial results with consolidated net sales increasing 22% year-over-year to $2.4 billion. While GAAP net earnings fell 57% due to earnout valuation adjustments and restructuring costs, adjusted diluted EPS grew 34% to $3.59, driven by strong performance in infrastructure hardware and cloud services.

Term
Q3 2026

“We delivered another strong quarter, with broad-based momentum across our business. Gross profit increased 20%, adjusted earnings from operations grew 23%, and adjusted diluted earnings per share increased 34%.”

Jack Azagury, President and Chief Executive Officer

“We continue to see strong performance in our strategic growth priorities, with infrastructure hardware gross profit increasing more than 50% and more than 20% gross profit growth across Cloud and Insight Core Services.”

Jack Azagury, President and Chief Executive Officer
8:08 AM ET 8-K
Reverse Stock Split InMed Pharmaceuticals Inc. MTRI

InMed Pharmaceuticals Reverse Stock Split

InMed Pharmaceuticals completed a 1-for-10 reverse stock split (consolidation), reducing its outstanding shares from approximately 5.49 million to 549,374. The company also legally changed its name to Mentari Therapeutics, Inc. and confirmed shareholder approval of all matters at its 2026 Annual General and Special Meeting.

8:08 AM ET 8-K
Financial Results Acorn Energy, Inc. ACFN

Acorn Energy Financial Results

Acorn Energy reported Q3 2026 revenue growth of 4.6% to $2.59 million and net income of $0.94 million, which included a $780,000 deferred income tax benefit. During the quarter, the company completed the acquisition of Gen-Tracker to expand its commercial generator monitoring portfolio and annual recurring revenue.

Term
Q3 2026

“Our third quarter was a solid, cash-generative quarter driven by a 4.6% revenue increase compared to Q3’25, with approximately $1M of cash generated from operations. Our Q3’26 EPS included a $730,000 income tax benefit related to a further reduction in the valuation allowance on our deferred tax assets, reflecting increased confidence in our ability to utilize our net operating loss (NOL) carryforwards in the future.”

Jan Loeb, Acorn’s CEO
8:08 AM ET 8-K
Financial Results Vericel Corp VCEL

Vericel Financial Results

Vericel reported third quarter 2026 total revenue growth of 26% to $85.4 million and a 179% increase in net income to $14.2 million. Driven by strong performance in its MACI and Burn Care segments, the company raised its full-year 2026 revenue guidance to a range of $344 million to $346 million.

Term
Q3 2026

“The Company delivered outstanding financial and business results in the third quarter as we continue to generate top-tier revenue and profit growth as well as significant free cash flow, while also returning capital to shareholders.”

Nick Colangelo, President and CEO of Vericel

“Given our third quarter outperformance and the strong start to the fourth quarter for both commercial businesses, and particularly for MACI, we believe that the Company is very well-positioned for a strong close to 2026 and to sustain this momentum in 2027 and beyond.”

Nick Colangelo, President and CEO of Vericel

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.